BUCCASTEM 3mg price in UAE

Overview

Welcome to Dwaey, specifically on BUCCASTEM 3mg Tablets/Buccal page.
This medicine contains an important and useful components, as it consists of Prochlorperazine maleate.
BUCCASTEM 3mg is available in the market in concentration 3mg/Tablet and in the form of Tablets/Buccal.

RECKITT & COLMAN is the producer of BUCCASTEM 3mg and it is imported from UK, The most popular alternatives of BUCCASTEM 3mg are listed downward .

Mode Of Action

Prochlorperazine blocks both postsynaptic dopamine receptors as well as the medullary chemo receptor trigger zone. It depresses hypothalamic and hypophyseal hormone release and posssesses alpha-adrenergic and anticholinergic inhibitory activity.

Indication

Vertigo
Psychoses
Nausea and vomiting
Severe anxiety disorders

Precaution

Extrapyramidal syndrome, hypotension, epilepsy, impaired hepatic, renal, CV, cerebrovascular or respiratory function, glaucoma. May impair ability to drive or perform tasks requiring mental alertness or physical coordination. Parenteral use in children is not recommended. History of jaundice, parkinsonism, diabetes mellitus, hypothyroidism, myasthenia gravis, paralytic ileus, prostatic hyperplasia or urinary retention. Regular eye examinations are recommended in patients on long-term treatment. Lactation: Phenothiazines may be excreted in breast milk; do not nurse

Side Effects

<1% Insomnia
Restlessness
Dizziness
Anxiety
Euphoria
Agitation
Depression
Weakness
Headache
Cerebral edema
Poikilothermia
Tachycardia
ECG changes
Anorexia
Dyspepsia
Constipation
Diarrhea
Ileus
Blood dyscrasia
Galactorrhea
Gynecomastia
Ejaculatory disorder
Lens opacities (with prolonged use)
Photosensitivity
Pruritus Frequency Not Defined Akathisia
Sedation
Anticholinergic effects
Weight gain
Oligomenorrhea or amenorrhea
Erectile dysfunction
Extrapyramidal symptoms (muscle stiffness
dystonia
parkinsonism
tardive dyskinesia)
Neuroleptic malignant syndrome (infrequent but serious)
Seizure
Decreased gag reflex
Confusion
Hypotension
Hypertension
Leukopenia
Agranulocytosis
Cholestatic jaundice
Photosensitivity reaction
Priapism
Hepatotoxicity Potentially Fatal: Bone-marrow suppression. Cardiac arrhythmias or aspiration.

Contra indication

CNS depression, comatose patients. Bone marrow depression, phaechromocytoma, prolactin-dependent tumours, hypersensitivity. Childn <2 yr. Pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Additive anticholinergic effects with antihistamines, tricyclic antidepressants and drugs used in parkinsonism. May reduce the antihypertensive effect of guanethidine and other adrenergic neurone blockers. May also increase risk of arrhythmias when used with drugs that prolong QT interval. Potentially Fatal: Potentiation of other CNS depressants including alcohol, sedatives, hypnotics, barbiturates, opioids, antihistamines and general anaesthetics.